GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (XPAR:ALCLS) » Definitions » Other Liabilities for Insurance Companies

Cellectis (XPAR:ALCLS) Other Liabilities for Insurance Companies


View and export this data going back to 2007. Start your Free Trial

What is Cellectis Other Liabilities for Insurance Companies?

Other Liabilities for Insurance Companies only applies to insurance companies.


Cellectis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (XPAR:ALCLS) » Definitions » Other Liabilities for Insurance Companies
Traded in Other Exchanges
Address
8, rue de la Croix Jarry, Paris, FRA, 75013
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.